REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

ZSOKA es TARSA Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: ZSOKA es TARSA Bt. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

ZSOKA es TARSA Bt. is a company in Hungary, with a head office in Hernadnemeti. The enterprise operates in the Pharmacies and Drug Stores industry. It was established on December 15, 1993. 3 (2024) employees currently work for ZSOKA es TARSA Bt.. From the latest financial highlights, ZSOKA es TARSA Bt. reported a net sales revenue increase of 9.98% in 2024. During that time, ZSOKA es TARSA Bt.’s total assets grew by 2.32%. In 2024, ZSOKA es TARSA Bt.’s net profit margin decreased by 1.04%.

Headquarters
Petofi u. 124.
Hernadnemeti; Borsod-Abauj-Zemplen; Postal Code: 3564

Contact Details: Purchase the ZSOKA es TARSA Bt. report to view the information.

Website: http://www.hngyogyszertar.extra.hu

Basic Information
Total Employees:
Purchase the ZSOKA es TARSA Bt. report to view the information.
Registered Capital:
Purchase the ZSOKA es TARSA Bt. report to view the information.
Financial Auditors:
Purchase the ZSOKA es TARSA Bt. report to view the information.
Incorporation Date:
December 15, 1993
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
VIRIDIS-PHARMA KFT.
Company Performance
Financial values in the chart are available after ZSOKA es TARSA Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.98%▲
Total operating revenue
10.22%▲
Operating profit (EBIT)
-8.48%▼
EBITDA
-8.2%▼
Net Profit (Loss) for the Period
-8.36%▼
Total Assets
2.32%▲
Total Equity
-2.26%▼
Operating Profit Margin (ROS)
-1.13%▼
Net Profit Margin
-1.04%▼
Return on Equity (ROE)
-1.67%▼
Quick Ratio
-6.34%▼
Cash Ratio
-5.86%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo